Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze OXBDF stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate OXBDF investment potential.

What is OXBDF stock price today?

Get real-time OXBDF stock price, historical data, and price charts on Financhill. Track OXBDF performance with our advanced analysis tools.

Is OXBDF a good investment?

Evaluate OXBDF investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy OXBDF stock?

To buy OXBDF stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of OXBDF?

View detailed market capitalization data and company valuation metrics for OXBDF on our comprehensive analysis page.

What is the P/E ratio of OXBDF?

Use our fundamental analysis tools to view OXBDF P/E ratio and compare valuation metrics with industry peers.

What are OXBDF earnings?

View OXBDF earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Oxford Biomedica Plc 10K Form

Buy

OXBDF
Oxford Biomedica Plc

Last Price:

$11.34

Seasonality Move:

4.62%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive OXBDF News And Ratings

See the #1 stock for the next 7 days that we like better than OXBDF

OXBDF Financial Statistics

Sales & Book Value

Annual Sales:	$164.6M
Cash Flow:	$0
Price / Cash Flow:	0
Annual Sales:	$0.80
Price / Book:	9.28

Profitability

EPS (TTM):	-0.46900
Net Income (TTM):	$-50.6M
Gross Margin:	$66.9M
Return on Equity:	-120.93%
Return on Assets:	-46.7%

Oxford Biomedica Plc Earnings Forecast

Key Oxford Biomedica Plc Financial Ratios

The Gross Profit Margin over the past 18 years for OXBDF is 40.65%.
The Selling, General & Administrative Expenses for OXBDF have been equal to 22.84% of Gross Profit Margin.
The Research & Development expenses have been 52.92% of Revenue.
The Net Earning history of OXBDF is -37.74% of Total Revenues.
Per Share Earnings over the last 29 years have been positive in 17 years.

Oxford Biomedica Plc Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	OTCM
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	OXBDF
Website:	oxfordbiomedica.co.uk

Debt

Debt-to-Equity Ratio:	0.6
Current Ratio:	2.35
Quick Ratio:	1.99

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

OXBDF Technical Analysis vs Fundamental Analysis

Buy

Oxford Biomedica Plc (OXBDF) is a Buy

Is Oxford Biomedica Plc a Buy or a Sell?

Oxford Biomedica Plc stock is rated a Buy

The current Oxford Biomedica Plc [OXBDF] share price is $11.34. The Score for OXBDF is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.